Concepedia

Elena Yureneva

EY

Statistics

Publications

5

Citations

818

H-Index

5

Active since

2023

Affiliations

Alnylam Pharmaceuticals (United States)(Current)

University College London

Boston University

Mayo Clinic

Harvard University

Elena Yureneva is an author at Alnylam Pharmaceuticals (United States) specializing in medicine, clinical cardiology, and hereditary amyloidosis.

Publications per year

2023–2025

5

Publications

5

Vutrisiran in Patients with Transthyretin Amyloidosis with Cardiomyopathy

Marianna Fontana, John L. Berk, Julian D. Gillmore et al. · New England Journal of Medicine · 2024 · 362 citations · Full text

, , +11

Patisiran Treatment in Patients with Transthyretin Cardiac Amyloidosis

Mathew S. Maurer, Parag Kale, Marianna Fontana et al. · New England Journal of Medicine · 2023 · 307 citations · Full text

, , +7

Phase 2 Trial of Cemdisiran in Adult Patients with IgA Nephropathy: A Randomized Controlled Trial

Jonathan Barratt, Adrian Liew, See Cheng Yeo et al. · Clinical Journal of the American Society of Nephrology · 2024 · 66 citations · Full text

, , +17

Impact of Vutrisiran on Exploratory Cardiac Parameters in Hereditary Transthyretin-Mediated Amyloidosis with Polyneuropathy

Pablo García‐Pavía, Martha Grogan, Parag Kale et al. · European Journal of Heart Failure · 2024 · 52 citations · Full text

, , +7

Five-Year Results With Patisiran for Hereditary Transthyretin Amyloidosis With Polyneuropathy

David Adams, Jonas Wixner, Michael Polydefkis et al. · JAMA Neurology · 2025 · 31 citations · Full text

, , +13

1–5 of 5